Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lung Cancer

Clinical Trial at: Texas Oncology - Austin

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

901 W 38th Street, Suite 200
Austin, TX 78705
P: (512) 421-4100

More Details View Practice Page

Lung Cancer

Clinical Trial at: Comprehensive Cancer Centers of Nevada - Las Vegas

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

7445 Peak Dr
Las Vegas, NV 89128
P: (702) 952-2140

More Details View Practice Page

Lung Cancer

Clinical Trial at: Virginia Cancer Specialists - Fairfax

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

8503 Arlington Blvd, Suite 400
Fairfax, VA 22031
P: (703) 280-5390

More Details View Practice Page

Lung Cancer

Clinical Trial at: Comprehensive Cancer Centers of Nevada - Henderson

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

1505 Wigwam Pkwy, Suite 130
Henderson, NV 89074
P: (702) 856-1400

More Details View Practice Page

Lung Cancer

Clinical Trial at: 19192-Lung Cancer-NSCLC-632 -

A PHASE III, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF TIRAGOLUMAB, AN ANTI-TIGIT ANTIBODY,IN COMBINATION WITH ATEZOLIZUMAB COMPARED WITH PLACEBO IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PD-L1-SELECTED NON-SMALL CELL LUNG CANCER (GO41717)

  • Details

ClinicalTrials.gov ID: NCT04294810
Diagnosis Type: NSCLC
USOR Number: 19192

  • Practice Details


,
P:

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A PHASE III, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF TIRAGOLUMAB, AN ANTI-TIGIT ANTIBODY,IN COMBINATION WITH ATEZOLIZUMAB COMPARED WITH PLACEBO IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PD-L1-SELECTED NON-SMALL CELL LUNG CANCER (GO41717)

  • Details

ClinicalTrials.gov ID: NCT04294810
Diagnosis Type: NSCLC
USOR Number: 19192

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, MN 55125
P: (651) 735-7414

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Round Rock

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

2410 Round Rock Ave, Suite 150
Round Rock, TX 78681
P: (512) 341-8724

More Details View Practice Page

Lung Cancer

Clinical Trial at: Virginia Cancer Specialists - Arlington

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

1635 N George Mason Dr, Suite 170
Arlington, VA 22205
P: (703) 894-3800

More Details View Practice Page

Lung Cancer

Clinical Trial at: 19192-Lung Cancer-NSCLC-482 -

A PHASE III, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF TIRAGOLUMAB, AN ANTI-TIGIT ANTIBODY,IN COMBINATION WITH ATEZOLIZUMAB COMPARED WITH PLACEBO IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PD-L1-SELECTED NON-SMALL CELL LUNG CANCER (GO41717)

  • Details

ClinicalTrials.gov ID: NCT04294810
Diagnosis Type: NSCLC
USOR Number: 19192

  • Practice Details


,
P:

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Austin

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

6204 Balcones Drive
Austin, TX 78731
P: (512) 427-9400

More Details View Practice Page